Información: Esta es una versión obsoleta del modelo de datos. En la sección izquierda, bajo "Versiones", se encuentra el historial de versiones. Puede acceder a la versión actual a través del siguiente link: here.
Información:
Error:
ID
34573
Descripción
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02240238
Link
https://clinicaltrials.gov/show/NCT02240238
Palabras clave
Versiones (3)
- 19/1/19 19/1/19 -
- 28/9/20 28/9/20 -
- 1/10/20 1/10/20 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
19 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Solid Tumors NCT02240238
Eligibility Solid Tumors NCT02240238
- StudyEvent: Eligibility
Similar models
Eligibility Solid Tumors NCT02240238
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
(part 1 only) have a histologically or cytologically confirmed diagnosis of advanced solid tumor that has relapsed or is refractory to standard curative or palliative therapy or has a contraindication to standard therapy.
boolean
ID.2
Item
(part 2 only) have histologically or cytologically confirmed diagnosis of stage iiib or iv nsclc and have received 1 or 2 lines of prior chemotherapy or targeted therapy for stage iiib or iv nsclc (second- or third-line).
boolean
ID.3
Item
have measurable disease per response evaluation criteria in solid tumors (recist) version 1.1.
boolean
ID.4
Item
eastern cooperative oncology group (ecog) performance status of 0 to 1
boolean
ID.5
Item
have adequate bone marrow reserve, liver function, and renal function
boolean
ID.6
Item
have received prior platinum therapy in the past 3 months
boolean
ID.7
Item
have received prior cisplatin and gemcitabine concomitantly within the last 6 months or are refractory to cisplatin and gemcitabine.
boolean
ID.8
Item
unresolved toxicity from prior radiation, chemotherapy, or other targeted treatment, including investigational treatment
boolean
ID.9
Item
pregnant or breast feeding
boolean